• S Matsunaga, K Ijiri, and H Koga.
• Department of Orthopaedic Surgery, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. shunji@med1.kufm.kagoshima-u.ac.jp
• Spine. 2000 Jul 15; 25 (14): 1749-53.

Study DesignEvaluation of results a longer than 10-year follow-up of patients with upper cervical lesions due to rheumatoid arthritis who underwent occipitocervical fusion.ObjectiveTo determine the final outcome of patients with upper cervical lesions due to rheumatoid arthritis treated by occipitocervical fusion.Summary Of Background DataThere are few studies reporting the final outcome of patients with rheumatoid arthritis treated by occipitocervical fusion and observed for longer than 10 years.MethodsThe subjects were 16 patients with rheumatoid arthritis with myelopathy who underwent occipitocervical fusion with a rectangular rod more than 10 years ago. All 16 patients had irreducible atlantoaxial dislocation, and 11 also had vertical dislocation of the axis. All patients had preoperative nuchal pain, and were classified into Class II (two patients), Class IIIA (nine patients), and class IIIB (five patients) according to Ranawat's preoperative neurologic classification.ResultsThe atlas-dens interval remained the same as immediately after surgery. Vertical dislocation returned to the preoperative condition, despite successful surgical correction. Preoperative occipital pain disappeared or was reduced in all cases. Myelopathy improved in 12 of the 16 patients (75%) by more than one class in the Ranawat preoperative neurologic classification. Survival rate at 10 years after surgery was 38%; mean age at death was 70.7 years. The postoperative periods during which patients could walk by themselves ranged from 6 months to 13 years (mean, 7.5 years).ConclusionsOccipitocervical fusion for patients with rheumatoid arthritis is useful for decreasing nuchal pain, reducing myelopathy, and improving prognosis.

38 keywords...

hide…